125 related articles for article (PubMed ID: 3755439)
21. Localization of neuropeptide Y and norepinephrine in the porcine ovarian artery and their influence on the local blood pressure.
Markiewicz W; Jaroszewski JJ; Barszczewska B; Sienkiewicz W
Folia Histochem Cytobiol; 2003; 41(2):73-81. PubMed ID: 12722792
[TBL] [Abstract][Full Text] [Related]
22. Endothelium removal does not affect potentiation by neuropeptide Y in rabbit ear artery.
Budai D; Vu HQ; Duckles SP
Eur J Pharmacol; 1989 Sep; 168(1):97-100. PubMed ID: 2583236
[TBL] [Abstract][Full Text] [Related]
23. Effects of neuropeptide Y on the response of isolated blood vessels to norepinephrine and sympathetic field stimulation.
Hieble JP; Duesler JG; Daly RN
J Pharmacol Exp Ther; 1989 Aug; 250(2):523-8. PubMed ID: 2668503
[TBL] [Abstract][Full Text] [Related]
24. Neuropeptide Y (NPY) reduces field stimulation-evoked release of noradrenaline and enhances force of contraction in the rat portal vein.
Dahlöf C; Dahlöf P; Tatemoto K; Lundberg JM
Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):327-30. PubMed ID: 3838576
[TBL] [Abstract][Full Text] [Related]
25. Interaction of peptides present in perivascular nerves on the smooth muscle of cat cerebral arteries and on the stimulation-evoked efflux of 3H-noradrenaline.
Edvinsson L; Skärby T
J Auton Pharmacol; 1984 Sep; 4(3):193-8. PubMed ID: 6593321
[TBL] [Abstract][Full Text] [Related]
26. Heterogeneity of the neuropeptide Y (NPY) contractile and relaxing receptors in horse penile small arteries.
Prieto D; Arcos LR; Martínez P; Benedito S; García-Sacristán A; Hernández M
Br J Pharmacol; 2004 Dec; 143(8):976-86. PubMed ID: 15557288
[TBL] [Abstract][Full Text] [Related]
27. Prominent sympathetic purinergic vasoconstriction in the rabbit splenic artery: potentiation by 2,2'-pyridylisatogen tosylate.
Ren LM; Burnstock G
Br J Pharmacol; 1997 Feb; 120(3):530-6. PubMed ID: 9031760
[TBL] [Abstract][Full Text] [Related]
28. Neuropeptide Y and sympathetic vascular control in man.
Lundberg JM; Torssell L; Sollevi A; Pernow J; Theodorsson Norheim E; Anggård A; Hamberger B
Regul Pept; 1985 Dec; 13(1):41-52. PubMed ID: 3841402
[TBL] [Abstract][Full Text] [Related]
29. Neurogenically evoked cerebral artery constriction is mediated by neuropeptide Y.
Laher I; Germann P; Bevan JA
Can J Physiol Pharmacol; 1994 Sep; 72(9):1086-8. PubMed ID: 7842391
[TBL] [Abstract][Full Text] [Related]
30. Potentiation by neuropeptide Y of vasoconstriction in rat resistance arteries.
Andriantsitohaina R; Stoclet JC
Br J Pharmacol; 1988 Oct; 95(2):419-28. PubMed ID: 2465806
[TBL] [Abstract][Full Text] [Related]
31. Enhanced neuropeptide Y immunoreactivity and vasoconstriction in mesenteric small arteries from spontaneously hypertensive rats.
Gradin KA; Li JY; Andersson O; Simonsen U
J Vasc Res; 2003; 40(3):252-65. PubMed ID: 12902638
[TBL] [Abstract][Full Text] [Related]
32. Neuropeptide Y is released from human mammary and radial vascular biopsies and is a functional modulator of sympathetic cotransmission.
Donoso MV; Miranda R; Irarrázaval MJ; Huidobro-Toro JP
J Vasc Res; 2004; 41(5):387-99. PubMed ID: 15377822
[TBL] [Abstract][Full Text] [Related]
33. Increased sensitivity of rabbit ear artery to noradrenaline following perivascular nerve stimulation may be a response to neuropeptide Y released as cotransmitter.
Glover WE
Clin Exp Pharmacol Physiol; 1985; 12(3):227-30. PubMed ID: 3839723
[TBL] [Abstract][Full Text] [Related]
34. Neuropeptide Y-, substance P- and VIP-immunoreactive nerves in cat spleen in relation to autonomic vascular and volume control.
Lundberg JM; Anggård A; Pernow J; Hökfelt T
Cell Tissue Res; 1985; 239(1):9-18. PubMed ID: 2578317
[TBL] [Abstract][Full Text] [Related]
35. Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides.
Wahlestedt C; Yanaihara N; Håkanson R
Regul Pept; 1986 Feb; 13(3-4):307-18. PubMed ID: 3010387
[TBL] [Abstract][Full Text] [Related]
36. Effects of neuropeptide Y, calcitonin gene-related peptide, substance P, and capsaicin on cerebral arteries in man and animals.
Mejia JA; Pernow J; von Holst H; Rudehill A; Lundberg JM
J Neurosurg; 1988 Dec; 69(6):913-8. PubMed ID: 2461438
[TBL] [Abstract][Full Text] [Related]
37. Distribution and functional effects of neuropeptide Y on equine ureteral smooth muscle and resistance arteries.
Prieto D; Hernández M; Rivera L; García-Sacristán A; Simonsen U
Regul Pept; 1997 Apr; 69(3):155-65. PubMed ID: 9226400
[TBL] [Abstract][Full Text] [Related]
38. Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide Y.
Lundberg JM; Pernow J; Franco-Cereceda A; Rudehill A
J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S51-68. PubMed ID: 2455193
[TBL] [Abstract][Full Text] [Related]
39. Neuropeptide Y potentiates purinergic as well as adrenergic responses of the rabbit ear artery.
Saville VL; Maynard KI; Burnstock G
Eur J Pharmacol; 1990 Feb; 176(2):117-25. PubMed ID: 2311663
[TBL] [Abstract][Full Text] [Related]
40. Nerve fibers containing neuropeptide Y in the cerebrovascular bed: immunocytochemistry, radioimmunoassay, and vasomotor effects.
Edvinsson L; Copeland JR; Emson PC; McCulloch J; Uddman R
J Cereb Blood Flow Metab; 1987 Feb; 7(1):45-57. PubMed ID: 3805164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
